close
This ad will auto close in 10 seconds

Cipla grants global rights to Meda for nasal spray 'Dymista'

Cipla Wednesday said it has granted the global commercialisation rights for its nasal spray 'Dymista' to Swedish partner Meda AB except for certain geographies.